This valuable study reports on a novel role of PD-1 in early T cell differentiation, showing that PD-1 stimulation impairs Th2 differentiation more effectively than that of Th1, with implications for ...

When I was diagnosed with lung cancer, I didn’t want to receive chemotherapy, especially when I was a good candidate for ...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As ...

It is Transgene's second most advanced neoantigen immunotherapy programme after TG4050 for head and neck cancer, which is in ...

Alameda, California Tuesday, October 15, 2024, 14:00 Hrs [IST] ...

That brings us to Summit Therapeutics (NASDAQ: SMMT), a drugmaker whose shares have skyrocketed by almost 700% since the year ...

Researchers have discovered that combining immunotherapy and chemotherapy can overcome treatment resistance in a subset of ...

Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that patients with metastatic ...

Merck & Co. hopes a new positive trial readout can return Keytruda to glory in head and neck cancer. | Merck & Co. hopes a ...

*仅供医学专业人士阅读参考在目前已经获批的各种免疫联合治疗方案里，PD-1/L1抑制剂和CTLA-4抑制剂组成的“双免疫方案”，经常给奇点糕一种双刃剑的感觉，一方面它们确实取得了不少关键临床研究的成功，对非小细胞肺癌（NSCLC）、肝癌等常见实体瘤有 ...

Leads Biolabs’ LBL-024 receives Breakthrough Therapy Designation from China NMPA to treat extrapulmonary neuroendocrine carcinoma: Nanjing, China Thursday, October 10, 2024, 10: ...